Literature DB >> 26721824

Impact of bloodstream infections on catheter colonization during extracorporeal membrane oxygenation.

Dong Wan Kim1, Hye Ju Yeo1, Seong Hoon Yoon1, Seung Eun Lee1, Su Jin Lee1, Woo Hyun Cho2, Doo Soo Jeon1, Yun Seong Kim1, Bong Soo Son3, Do Hyung Kim3.   

Abstract

There are concerns about secondary extracorporeal membrane oxygenation (ECMO) catheter infections in bacteremic patients. We investigated the association between blood stream infection (BSI) and ECMO catheter colonization. From January 2012 to August 2014, 47 adults who received ECMO support were enrolled. The ECMO catheter tip was cultured at the end of the ECMO procedure. The enrolled patients were classified into two groups according to the presence of BSI during ECMO support and analyzed with respect to ECMO catheter colonization. Of 47 cases, BSI during ECMO was identified in 13 patients (27.7 %). ECMO catheter colonization was identified in 6 (46.2 %) patients in the BSI group and 3 (8.8 %) in the non-BSI group. BSI during ECMO support was independently associated with ECMO catheter colonization [odds ratio (OR) 5.55; 95 % confidence interval (CI) 1.00-30.73; p = 0.049]. The organisms colonizing ECMO catheters in the setting of primary BSI were predominantly Gram-positive cocci and Candida species. Acinetobacter baumannii was the most common colonizing pathogen in the setting of secondary BSI. All the organisms colonizing ECMO catheters were multi-drug resistant organisms, including methicillin-resistant S. aureus, Candida glabrata, and carbapenem-resistant A. baumannii. ECMO catheters may become contaminated with multi-drug resistant pathogens in the presence of BSI. Therefore, ECMO should be applied cautiously in septic patients with bacteremia caused by multi-drug resistant pathogens.

Entities:  

Keywords:  Blood stream infection; Catheter-related infection; Extracorporeal membrane oxygenation

Mesh:

Year:  2015        PMID: 26721824     DOI: 10.1007/s10047-015-0882-5

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  23 in total

1.  Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: an analysis of the registry data of the extracorporeal life support organization.

Authors:  B H Douglass; A L Keenan; D M Purohit
Journal:  Artif Organs       Date:  1996-03       Impact factor: 3.094

2.  Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery.

Authors:  V L Montgomery; J M Strotman; M P Ross
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

3.  Microbiology of indwelling central intravascular catheters.

Authors:  T M Haslett; H D Isenberg; E Hilton; V Tucci; B G Kay; E M Vellozzi
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

4.  Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease.

Authors:  A P Goldman; S J Kerr; W Butt; M J Marsh; I A Murdoch; T Paul; R K Firmin; R C Tasker; D J Macrae
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

5.  Extracorporeal life support for children with meningococcal septicaemia.

Authors:  D K Luyt; J Pridgeon; J Brown; G Peek; R Firmin; H C Pandya
Journal:  Acta Paediatr       Date:  2004-12       Impact factor: 2.299

6.  Healthcare-associated infection in pediatric patients on extracorporeal life support: The role of multidisciplinary surveillance.

Authors:  Kate L Brown; Deborah A Ridout; Mike Shaw; Iris Dodkins; Liz C Smith; Maura A O'Callaghan; Allan P Goldman; Susan Macqueen; John C Hartley
Journal:  Pediatr Crit Care Med       Date:  2006-11       Impact factor: 3.624

Review 7.  Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience.

Authors:  Gregor W Kaczala; Stephane C Paulus; Nawaf Al-Dajani; Wilson Jang; Edith Blondel-Hill; Simon Dobson; Arthur Cogswell; Avash J Singh
Journal:  Pediatr Surg Int       Date:  2009-01-16       Impact factor: 1.827

8.  Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome.

Authors:  Cecile Aubron; Allen C Cheng; David Pilcher; Tim Leong; Geoff Magrin; D Jamie Cooper; Carlos Scheinkestel; Vince Pellegrino
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

9.  Extracorporeal membrane oxygenation for refractory septic shock in children.

Authors:  J Beca; W Butt
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

10.  Risk factors for nosocomial infection during extracorporeal membrane oxygenation.

Authors:  M-S Hsu; K-M Chiu; Y-T Huang; K-L Kao; S-H Chu; C-H Liao
Journal:  J Hosp Infect       Date:  2009-09-25       Impact factor: 3.926

View more
  16 in total

Review 1.  Journal of Artificial Organs 2016: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; G Matsumiya; K Matsuda; E Tatsumi; T Abe; K Fukunaga; S Ichiba; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2017-02-14       Impact factor: 1.731

2.  A novel survival prediction model of ECMO in acute respiratory distress syndrome: things to consider for optimal use.

Authors:  Hye Ju Yeo; Woo Hyun Cho
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 3.  Outcome and Clinical Characteristics of Nosocomial Infection in Adult Patients Undergoing Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.

Authors:  Xiyuan Li; Liangshan Wang; Hong Wang; Xiaotong Hou
Journal:  Front Public Health       Date:  2022-06-24

4.  Indwelling Central Venous Catheters Drive Bloodstream Infection During Veno-venous Extracorporeal Membrane Oxygenation Support.

Authors:  Adwaiy Manerikar; Satoshi Watanabe; Viswajit Kandula; Azad Karim; Sanket Thakkar; Mark Saine; Samuel S Kim; Rafael Garza-Castillon; David D Odell; Ankit Bharat; Chitaru Kurihara
Journal:  ASAIO J       Date:  2022-09-28       Impact factor: 3.826

5.  Risk factors for complete recovery of adults after weaning from veno-venous extracorporeal membrane oxygenation for severe acute respiratory failure: an analysis from adult patients in the Extracorporeal Life Support Organization registry.

Authors:  Hye Ju Yeo; Yun Seong Kim; Dohyung Kim; Woo Hyun Cho
Journal:  J Intensive Care       Date:  2020-08-20

6.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

7.  Fungal infections in adult patients on extracorporeal life support.

Authors:  Yiorgos Alexandros Cavayas; Hakeem Yusuff; Richard Porter
Journal:  Crit Care       Date:  2018-04-17       Impact factor: 9.097

8.  Clinical outcomes according to cannula configurations in patients with acute respiratory distress syndrome under veno-venous extracorporeal membrane oxygenation: a Korean multicenter study.

Authors:  Sung Yoon Lim; Soyeon Ahn; Sang-Bum Hong; Chi Ryang Chung; Kyeongman Jeon; Sang-Min Lee; Woo Hyun Cho; Sunghoon Park; Young-Jae Cho
Journal:  Ann Intensive Care       Date:  2020-06-22       Impact factor: 6.925

Review 9.  ECLS-associated infections in adults: what we know and what we don't yet know.

Authors:  Darryl Abrams; Giacomo Grasselli; Matthieu Schmidt; Thomas Mueller; Daniel Brodie
Journal:  Intensive Care Med       Date:  2019-11-25       Impact factor: 41.787

10.  Chlorhexidine bathing of the exposed circuits in extracorporeal membrane oxygenation: an uncontrolled before-and-after study.

Authors:  Hye Ju Yeo; Dohyung Kim; Mihyang Ha; Hyung Gon Je; Jeong Soo Kim; Woo Hyun Cho
Journal:  Crit Care       Date:  2020-10-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.